Food and Drug Administration
The FDA, a US federal agency, offers grants for research, training, and public health programs.
Get Funding to Improve Medical Product Regulation in the Americas
This funding opportunity supports organizations working to strengthen medical product regulatory systems in the Americas by developing standards, analyzing system performance, and providing technical assistance. If your organization is involved in improving the safety and quality of medical products regionally, you may be eligible for this grant.
Unlock Global Market Access: Food Safety Grants
Are you involved in international trade or food production? This grant funds research and capacity building to strengthen global food safety systems, helping you meet international standards and access new markets.
Unlock FDA Grant Funding for Drug Development
This FDA grant supports collaborations with established consortia to advance drug development tools and biomarkers. Businesses can leverage existing expertise and resources to accelerate critical research and innovation.
FDA Grants for Kidney Health Innovation
This grant from the FDA supports initiatives focused on improving kidney health. It's specifically for organizations dedicated to advancing research and development in this critical area.
FDA Grant: Boost Pediatric Drug Research
This grant from the FDA supports research into how common foods and formulas affect the performance of pediatric medications. Eligible researchers can secure funding to conduct vital studies that could improve drug treatments for children.
FDA Grant: Boost Drug Performance & Predict Success
This FDA grant invites research into advanced in vitro methods to predict how drugs, like furosemide, will perform in the body. Businesses can gain funding to explore new techniques for characterizing drug dissolution in complex media, ultimately leading to better product development.
Get Grants for Pediatric Health Research Funding
This grant supports research into the safety of polyethylene glycol (PEG) products for children experiencing constipation. Funding is available for studies aimed at understanding potential side effects and accumulation of specific compounds.
Grant for Better Clinical Trials: Get Funding!
This grant from the FDA's CDER is seeking to fund Duke University's Duke Translational Medicine Institute to improve the quality and efficiency of clinical trials. Businesses involved in clinical trial innovation may benefit from this initiative.
Unlock FDA Funding for Complex Molecule Drug Development
This grant from the FDA supports businesses developing innovative mathematical models to streamline the comparison of complex drug molecules. Fund your research to accelerate the approval of generic and follow-on versions of essential medications.
Get Funding to Boost Pharma Manufacturing!
Are you a pharmaceutical manufacturer focused on solid-based drug products? This grant funds the development of advanced simulation and modeling tools to improve your risk assessment, control strategies, and product quality.
Fund Your Drug Development Data Standards
Are you involved in clinical research and drug development? This grant supports the creation of standardized data concepts and terminology, aiming to streamline regulatory reviews and accelerate the path to new therapies.
Unlock Funding for Pharma Research & Development
Are you in the pharmaceutical industry, specifically focusing on generic drug development? This grant supports research to improve generic drug acceptance and ensure public safety, potentially leading to FDA regulatory science advancements.
Get Funding for ADHD Drug Research!
Researchers and companies developing extended-release methylphenidate products for ADHD can apply for funding to conduct studies. This grant supports research to ensure the therapeutic equivalence and effectiveness of these crucial medications.
Unlock Funding for Drug Safety & Efficacy Research
This grant is for researchers and organizations looking to improve drug safety monitoring and evaluate generic drug performance. Funding will support the development of new methods to track drug efficacy, usage, and substitution patterns, ultimately ensuring better patient outcomes.
Unlock Grant Funding for Medical Research & Innovation
This grant opportunity funds retrospective research analyzing the impact of generic immunosuppressants on organ transplant outcomes. Eligible applicants can receive funding to evaluate the effectiveness and safety of generic medications compared to their brand-name counterparts.
Get Funding for Drug Development Research
This grant supports research into improving the effectiveness and consistency of solid dispersion drug formulations. Businesses can receive funding to investigate different manufacturing methods and analytical techniques to ensure drug quality and performance.
Unlock Funding for Drug Research & Development
This grant supports research focused on understanding how cardiovascular drugs like metoprolol behave in the body and affect patients, particularly concerning generic alternatives and patient factors. Businesses involved in pharmaceutical development and clinical trials can apply to conduct crucial PK-PD studies to ensure drug equivalence and patient safety.
Get Funding: Improve Transplant Outcomes with Drug Studies
This grant supports prospective studies investigating how generic immunosuppressants affect transplant patient and graft survival, aiming to build confidence in their use. Researchers and healthcare institutions can apply to conduct these critical clinical outcome studies.
Funded Research: Advance Medical Treatments
This grant funds research to evaluate the safety and efficacy of generic parenteral iron injection treatments, ensuring they meet rigorous FDA standards for treating anemia and supporting advancements in medical product evaluation.
Get Funding for MDI Dose Counter Innovation
This grant supports businesses developing advanced in vitro testing methods to ensure the accuracy and reliability of dose counters in metered dose inhalers. Fund innovative solutions that improve MDI drug product performance and predict real-world usage failures.